Strengthening Exercises in Shoulder Impingement (SExSI) Trial

January 22, 2020 updated by: Mikkel Bek Clausen, Copenhagen University Hospital, Hvidovre

The Effects of Additional Home-based Strengthening Exercises in Shoulder Impingement Rehabilitation (The SEXSI-Trial): A Pragmatic Randomized Controlled Trial.

This study evaluates the addition of a high dose of simple home-based elastic band strengthening exercises to usual care in patients with subacromial impingement syndrome. Half of the participants receive instructions in simple home-based elastic band strengthening exercises in addition to usual care, while the other half receive usual care.

Study Overview

Detailed Description

The SEXSI trial is a pragmatic, assessor and participant blinded, randomized, controlled, superiority trial, with a two-group parallel design. Patients with subacromial impingement syndrome will be randomized to either usual care or a home-based intervention consisting of progressive high volume resistance training in addition to usual care using a 1:1 allocation. The primary end-point will be change in the Shoulder Pain and Disability Index (SPADI) 16 weeks after baseline.

The overall frame for the trial is a main clinical effectiveness-part and an embedded mechanistic part. The clinical effectiveness-part will be reported in the main trial paper, and include the following outcomes: SPADI (primary outcome), Abduction strength, External rotation strength, Abduction ROM, Pain last week, QoL-index, QoL-VAS, Global impression of change and PASS. Missing outcome data will be imputed using multiple imputations based on the following variables: All previous scores in the relevant outcome, Age, Gender and Allocation.

A full trial protocol will be published and made publicly available. A constrained Linear Mixed Model (cLMM) will be applied for all continuous outcomes with Time Frame 16 weeks (including the primary outcome), to compare the change from baseline to 16 weeks in the intervention group (IG) to that in the control group (CG). The outcome at 16 weeks will be included as dependent variable, treatment group (IG or CG) as main effect and both baseline score and any additional follow up measurements as repeated measurements. The covariance structures will be selected based on the MAICE procedure. Binary outcomes will be reported as proportions with corresponding 95% confidence intervals, and will be compared using Chi-squared tests, and Odds Ratios computed from random effects logistic regression models. All of these analyses will be conducted as intention to treat (ITT) analyses, including all randomized participants, regardless of protocol adherence, meaning that all participants will be analysed as randomized. In the primary trial report, all collected outcomes will be listed, and it will be stated that the below-mentioned variables - belonging to the mechanistic part - will be reported in secondary publications.

The mechanistic part will be reported in secondary papers with a clear reference to the primary trial and trial registration, and it will hold the label "secondary analyses from a pragmatic randomized controlled trial" in the title. The following outcomes will be reported:

Outcomes regarding pain sensitization (temporal summation of pain, conditioned pain modulation, pain pressure threshold and pain catastrophizing) will be reported in a subsequent paper where we also plan to investigate:

  • the modifying effects of pain sensitization on the effectiveness of the add-on intervention
  • the dose-response relationship between objectively monitored adherence to the add-on intervention and change in SPADI, shoulder abduction strength and external rotation strength
  • the dose-response relationship between pain sensitization and change in SPADI, shoulder abduction strength and external rotation strength, and to what degree this is mediated through adherence to the intervention.

Outcomes regarding scapula dyskinesia and scapula dysfunction will be reported in another subsequent paper, were we also plan to investigate the modifying effects of scapula dyskinesia and scapula dysfunction on the effectiveness of the intervention on changes in SPADI, abduction strength and external rotation strength.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hvidovre, Denmark, 2650
        • Orthopaedic department, Hvidovre Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Convened for the first time to the clinic, for examination of their current shoulder disorder
  • Shoulder disorder lasting at least three months
  • Living in Capitol Region of Denmark
  • Not pregnant
  • Do not permanently use strong pain medication
  • Able to understand spoken and written Danish
  • ≥3 positive of the five diagnostic test for subacromial impingement syndrome (Hawkins-Kennedy test, Neer's test, pain-full arc, Resisted External Rotation test and Jobe's test)
  • Offered a rehabilitation plan due to a medically justified need for general rehabilitation after discharge from the hospital under the Danish Health Act § 140.
  • Completed Shoulder Pain And Disability Index (SPADI) questionnaire on the day of the medical examination

Exclusion Criteria:

  • A radiologically verified new or previous fracture related to the shoulder joint, including the scapula
  • Clinically suspected Glenohumeral osteoarthritis
  • A clinically suspected luxation or sub-luxation of the glenohumeral, acromioclavicular or sternoclavicular joint
  • A clinically suspected labral lesion, complete tear of the rotator cuff, frozen shoulder or other competing diagnoses (i.e. rheumatoid arthritis, cancer, neurological disorders, fibromyalgia, psychiatric illness)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Strengthen your Shoulder & Usual Care
Instructions in a home-based intervention consisting of progressive high volume resistance training with an elastic band. Instructions provided 0, 2, 5, and 10 weeks after baseline. Usual care includes all treatment received by a patient during the time between baseline and follow-up, except that included in "Strengthen your Shoulder".
A simple home-based elastic band strengthening exercise intervention. This program consists of progressive high volume resistance training exercises with an elastic band.
Usual care, consisting of a referral to general rehabilitation in the municipal under the Danish Health Act § 140, most often with the alternative option to choose a private physiotherapeutic clinic, partly at their own expense. Also includes any additional treatment the patient receives between baseline and follow-up, except that included in "Strengthen your Shoulder".
Active Comparator: Usual Care
Includes all treatment received by a patient during the time between baseline and follow-up, except that included in "Strengthen your Shoulder".
Usual care, consisting of a referral to general rehabilitation in the municipal under the Danish Health Act § 140, most often with the alternative option to choose a private physiotherapeutic clinic, partly at their own expense. Also includes any additional treatment the patient receives between baseline and follow-up, except that included in "Strengthen your Shoulder".

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SPADI
Time Frame: 16 weeks

Shoulder Pain And Disability Index score (continuous)

For all continuous outcomes with Time Frame 16 weeks, a constrained Linear Mixed Model (cLMM) is applied to compare the change from baseline to 16 weeks in the intervention group (IG) to that in the control group (CG), with the outcome at 16 weeks as dependent variable, treatment group (IG or CG) as main effect and both baseline score and any additional follow up measurements as repeated measurements. The covariance structures will be selected based on the MAICE procedure. These analyses will be conducted as intention to treat (ITT) analyses, including all randomized participants, regardless of protocol adherence. Participants will be analysed as randomized.

16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abduction strength
Time Frame: 16 weeks
Maximum isometric voluntary contraction in shoulder abduction (continuous)
16 weeks
External rotation strength
Time Frame: 16 weeks
Maximum isometric voluntary contraction in shoulder external rotation (continuous)
16 weeks
Abduction ROM
Time Frame: 16 weeks
Active range of motion in shoulder abduction (continuous)
16 weeks
Pain last week
Time Frame: 16 weeks
The average of least pain and average pain last week (continuous)
16 weeks
QoL-index
Time Frame: 16 weeks
Health related Quality of Life measured using the Danish EQ-5D-3L index (continuous)
16 weeks
QoL-index
Time Frame: 52 weeks
Health related Quality of Life measured using the Danish EQ-5D-3L index (continuous)
52 weeks
QoL-VAS
Time Frame: 16 weeks
Health related Quality of Life measured using the Danish EQ-5D-3L VAS (continuous)
16 weeks
QoL-VAS
Time Frame: 52 weeks
Health related Quality of Life measured using the Danish EQ-5D-3L VAS (continuous)
52 weeks
PCS
Time Frame: 16 weeks
Pain Catastrophizing measured using the Pain Catastrophizing Scale (continuous)
16 weeks
Temporal summation of pain (TS)
Time Frame: 16 weeks
The increase in pain recorded on an electronic VAS scale (range: 0-10 cm), during repeated standardized pressure induced pain stimuli (continuous)
16 weeks
CPM-Threshold
Time Frame: 16 weeks
Conditioned pain threshold modulation, the percent increase in pressure pain tolerance threshold, when experimental tonic pain is induced (continuous)
16 weeks
CPM-Detection
Time Frame: 16 weeks
Conditioned pain detection modulation, the percent increase in pressure pain detection threshold , when experimental tonic pain is induced (continuous)
16 weeks
PPT-deltoid
Time Frame: 16 weeks
Pain pressure threshold at the deltoid muscle: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).
16 weeks
PPT-Supraspinatus
Time Frame: 16 weeks
Pain pressure threshold at the supraspinatus muscle: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).
16 weeks
PPT-Infraspinatus
Time Frame: 16 weeks
Pain pressure threshold at the infraspinatus muscle: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).
16 weeks
PPT-worst
Time Frame: 16 weeks
Pain pressure threshold at the site of worst pain: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).
16 weeks
Sick leave
Time Frame: 52 weeks
The number of days with reported sick leave due to shoulder disorder (continuous)
52 weeks
Global impression of change
Time Frame: 16 weeks
Much improved or recovered? (Binary) Binary outcomes will be reported as proportions with corresponding 95% confidence intervals, and will be compared using a Chi-squared tests, and Odds Ratios computed from random effects logistic regression models.
16 weeks
PASS
Time Frame: 16 weeks
Patient Acceptable Symptom State: Is the symptom state acceptable? (Binary)
16 weeks
Surgery
Time Frame: 52 weeks
Surgery performed for the shoulder disorder? (Binary)
52 weeks
SDT
Time Frame: 16 weeks
Scapula dyskinesia measured using the Scapula Dyskinesia Test (Binary)
16 weeks
mSAT
Time Frame: 16 weeks
Scapula dysfunction measured using the modified Scapula Assistance Test (Binary)
16 weeks
SPADI
Time Frame: 52 weeks
Shoulder Pain And Disability Index score (continuous)
52 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mikkel B Clausen, PhD-Student, Bachelor's Degree Programme in Physiotherapy, Department of Physiotherapy and Occupational Therapy, Faculty of Health and Technology, Metropolitan University College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2016

Primary Completion (Actual)

October 29, 2018

Study Completion (Actual)

July 1, 2019

Study Registration Dates

First Submitted

April 19, 2016

First Submitted That Met QC Criteria

April 19, 2016

First Posted (Estimate)

April 21, 2016

Study Record Updates

Last Update Posted (Actual)

January 23, 2020

Last Update Submitted That Met QC Criteria

January 22, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subacromial Impingement Syndrome

Clinical Trials on Strengthen your Shoulder

Subscribe